A. Robinson, Swee Kwek, S. Kenney (2012)
The B-Cell Specific Transcription Factor, Oct-2, Promotes Epstein-Barr Virus Latency by Inhibiting the Viral Immediate-Early Protein, BZLF1PLoS Pathogens, 8
J. Siliciano, C. Canman, Y. Taya, K. Sakaguchi, E. Appella, M. Kastan (1997)
DNA damage induces phosphorylation of the amino terminus of p53.Genes & development, 11 24
Anaïs Pujals, B. Renouf, B. Renouf, Aude Robert, Sonia Chelouah, É. Hollville, É. Hollville, J. Wiels (2011)
Treatment with a BH3 mimetic overcomes the resistance of latency III EBV (+) cells to p53-mediated apoptosisCell Death & Disease, 2
Renfeng Li, Jian Zhu, Zhi Xie, Gangling Liao, Jianyong Liu, Mei-Ru Chen, Shaohui Hu, Crystal Woodard, Jimmy Lin, Sean D. Taverna, P. Desai, R. Ambinder, G. Hayward, Jiang Qian, Heng Zhu, S. Hayward (2011)
Conserved herpesvirus kinases target the DNA damage response pathway and TIP60 histone acetyltransferase to promote virus replication.Cell host & microbe, 10 4
F. Maly, A. Cross, O. Jones, G. Wolf-Vorbeck, C. Walker, C. Dahinden, A. Weck (1988)
The superoxide generating system of B cell lines. Structural homology with the phagocytic oxidase and triggering via surface Ig.Journal of immunology, 140 7
Q. Meng, Stacy Hagemeier, Chad Kuny, R. Kalejta, S. Kenney (2010)
Simian Virus 40 T / t Antigens and Lamin A / C Small Interfering RNA Rescue the Phenotype of an Epstein-Barr Virus Protein Kinase ( BGLF 4 ) Mutant
K. Bieging, Alexandra Amick, R. Longnecker (2009)
Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesisProceedings of the National Academy of Sciences, 106
D. Walling, C. Flaitz, C. Nichols, S. Hudnall, K. Adler‐Storthz (2001)
Persistent productive Epstein-Barr virus replication in normal epithelial cells in vivo.The Journal of infectious diseases, 184 12
Stacy Hagemeier, E. Barlow, Ariel Kleman, S. Kenney (2011)
The Epstein-Barr Virus BRRF1 Protein, Na, Induces Lytic Infection in a TRAF2- and p53-Dependent MannerJournal of Virology, 85
I. Mellinghoff, M. Daibata, R. Humphreys, C. Mulder, K. Takada, T. Sairenji (1991)
Early events in Epstein-Barr virus genome expression after activation: regulation by second messengers of B cell activation.Virology, 185 2
M. Rowe, R. Khanna, C. Jacob, V. Argaet, A. Kelly, S. Powis, M. Belich, Deborah Groom‐Carter, Steve Lee, S. Burrows, J. Trowsdale, D. Moss, A. Rickinson (1995)
Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein‐Barr virus latent membrane protein‐1: coordinate up‐regulation of peptide transporters and HLA‐class I antigen expressionEuropean Journal of Immunology, 25
Shih-Shin Chang, You-Chang Lo, Huey‐Huey Chua, Hsin-Yi Chiu, S. Tsai, Jen‐Yang Chen, K. Lo, Ching-Hwa Tsai (2008)
Critical Role of p53 in Histone Deacetylase Inhibitor-Induced Epstein-Barr Virus Zta ExpressionJournal of Virology, 82
J. Smith, L. Tho, Naihan Xu, D. Gillespie (2010)
The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.Advances in cancer research, 108
Ian Hickson, Yan Zhao, C. Richardson, Sharon Green, N. Martin, Alisdair Orr, P. Reaper, S. Jackson, N. Curtin, G. Smith (2004)
Identification and Characterization of a Novel and Specific Inhibitor of the Ataxia-Telangiectasia Mutated Kinase ATMCancer Research, 64
T. Murata, Yoshitaka Sato, Sanae Nakayama, A. Kudoh, S. Iwahori, Hiroki Isomura, M. Tajima, Takayuki Hishiki, T. Ohshima, M. Hijikata, K. Shimotohno, T. Tsurumi (2009)
TORC2, a Coactivator of cAMP-response Element-binding Protein, Promotes Epstein-Barr Virus Reactivation from Latency through Interaction with Viral BZLF1 Protein*Journal of Biological Chemistry, 284
A. Nanbo, Kaori Inoue, Kumi Adachi-Takasawa, K. Takada (2002)
Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma.The EMBO journal, 21 5
R. Feederle, M. Kost, M. Baumann, A. Janz, E. Drouet, W. Hammerschmidt, H. Delecluse (2000)
The Epstein–Barr virus lytic program is controlled by the co‐operative functions of two transactivatorsThe EMBO Journal, 19
D. Schultz, J. Friedman, F. Rauscher (2001)
Targeting histone deacetylase complexes via KRAB-zinc finger proteins: the PHD and bromodomains of KAP-1 form a cooperative unit that recruits a novel isoform of the Mi-2alpha subunit of NuRD.Genes & development, 15 4
Mei-Ru Chen, Shin-Jye Chang, H. Huang, Jen‐Yang Chen (2000)
A Protein Kinase Activity Associated with Epstein-Barr Virus BGLF4 Phosphorylates the Viral Early Antigen EA-D In VitroJournal of Virology, 74
A. Robinson, Swee Kwek, Stacy Hagemeier, C. Wille, S. Kenney (2011)
Cellular Transcription Factor Oct-1 Interacts with the Epstein-Barr Virus BRLF1 Protein To Promote Disruption of Viral LatencyJournal of Virology, 85
S. Lassoued, Bochra Gargouri, A. Feki, Hammadi Attia, J. Pelt (2009)
Transcription of the Epstein–Barr Virus Lytic Cycle Activator BZLF-1 During Oxidative Stress InductionBiological Trace Element Research, 137
R. Ju, M. Muller (2003)
Histone deacetylase inhibitors activate p21(WAF1) expression via ATM.Cancer research, 63 11
P. Nikitin, Chris Yan, E. Forte, A. Bocedi, Jason Tourigny, Robert White, M. Allday, Amee Patel, S. Dave, William Kim, Katherine Hu, Jing Guo, David Tainter, E. Rusyn, M. Luftig (2010)
An ATM/Chk2-mediated DNA damage responsive signaling pathway suppresses Epstein-Barr virus transformation of primary human B cellsCell host & microbe, 8
Courtney Shirley, Jianmeng Chen, Meir Shamay, Huili Li, C. Zahnow, S. Hayward, R. Ambinder (2011)
Bortezomib induction of C/EBPβ mediates Epstein-Barr virus lytic activation in Burkitt lymphoma.Blood, 117 23
T. Matozaki, C. Sakamoto, K. Matsuda, T. Suzuki, Y. Konda, O. Nakano, K. Wada, T. Uchida, H. Nishisaki, M. Nagao (1992)
Missense mutations and a deletion of the p53 gene in human gastric cancer.Biochemical and biophysical research communications, 182 1
Fengchun Ye, Fuchun Zhou, R. Bedolla, T. Jones, Xiu-fen Lei, Tao Kang, M. Guadalupe, Shou-Jiang Gao (2011)
Reactive Oxygen Species Hydrogen Peroxide Mediates Kaposi's Sarcoma-Associated Herpesvirus Reactivation from LatencyPLoS Pathogens, 7
Y. Hong, Seung-Woo Hong, Seung-mi Kim, D. Jin, Jae-Sik Shin, D. Yoon, Kyu-pyo Kim, Jae-Lyun Lee, D. Heo, Jung Lee, Tae Kim (2012)
Bortezomib induces G2-M arrest in human colon cancer cells through ROS-inducible phosphorylation of ATM-CHK1.International journal of oncology, 41 1
Kendra Cann, G. Dellaire (2011)
Heterochromatin and the DNA damage response: the need to relax.Biochemistry and cell biology = Biochimie et biologie cellulaire, 89 1
T. Ragoczy, L. Heston, G. Miller (1998)
The Epstein-Barr Virus Rta Protein Activates Lytic Cycle Genes and Can Disrupt Latency in B LymphocytesJournal of Virology, 72
P. Lieberman, J Hardwick, J. Sample, G. Hayward, S. Hayward (1990)
The zta transactivator involved in induction of lytic cycle gene expression in Epstein-Barr virus-infected lymphocytes binds to both AP-1 and ZRE sites in target promoter and enhancer regionsJournal of Virology, 64
Amy Ellis, Zhenxun Wang, Xianming Yu, J. Mertz (2010)
Either ZEB1 or ZEB2/SIP1 Can Play a Central Role in Regulating the Epstein-Barr Virus Latent-Lytic Switch in a Cell-Type-Specific MannerJournal of Virology, 84
Huey‐Huey Chua, Hsin-Yi Chiu, Sue‐Jane Lin, Pei-Lun Weng, Jiun-Han Lin, Shao-Wen Wu, S. Tsai, Ching-Hwa Tsai (2012)
p53 and Sp1 cooperate to regulate the expression of epstein–barr viral Zta proteinJournal of Medical Virology, 84
S. Bose, L. Yap, M. Fung, Jane Starzcynski, A. Saleh, S. Morgan, C. Dawson, M. Chukwuma, E. Maina, M. Buettner, Wenbin Wei, J. Arrand, Paul Lim, L. Young, S. Teo, T. Stankovic, C. Woodman, P. Murray (2009)
The ATM tumour suppressor gene is down‐regulated in EBV‐associated nasopharyngeal carcinomaThe Journal of Pathology, 217
S. Zalani, E. Holley-Guthrie, S. Kenney (1996)
Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism.Proceedings of the National Academy of Sciences of the United States of America, 93 17
P. Farrell, G. Allan, F. Shanahan, K. Vousden, T. Crook (1991)
p53 is frequently mutated in Burkitt's lymphoma cell lines.The EMBO Journal, 10
Renfeng Li, Leyao Wang, Gangling Liao, Catherine Guzzo, M. Matunis, Heng Zhu, S. Hayward (2012)
SUMO Binding by the Epstein-Barr Virus Protein Kinase BGLF4 Is Crucial for BGLF4 FunctionJournal of Virology, 86
Edward Gershburg, J. Pagano (2002)
Phosphorylation of the Epstein-Barr Virus (EBV) DNA Polymerase Processivity Factor EA-D by the EBV-Encoded Protein Kinase and Effects of the l-Riboside Benzimidazole 1263W94Journal of Virology, 76
A. Höglund, L. Nilsson, L. Forshell, K. Maclean, J. Nilsson (2009)
Myc sensitizes p53-deficient cancer cells to the DNA-damaging effects of the DNA methyltransferase inhibitor decitabine.Blood, 113 18
B. Neuhierl, R. Feederle, W. Hammerschmidt, H. Delecluse (2002)
Glycoprotein gp110 of Epstein–Barr virus determines viral tropism and efficiency of infectionProceedings of the National Academy of Sciences of the United States of America, 99
C. Borza, L. Hutt-Fletcher (2002)
Alternate replication in B cells and epithelial cells switches tropism of Epstein–Barr virusNature Medicine, 8
M. Masucci, Bertha Contreras-Salazar, E. Ragnar, K. Falk, J. Minárovits, I. Ernberg, G. Klein, Deparutenet, D. Rowe, C. Gregory, L. Young, P. Farrell, H. Rupani, A. Rickinson (1989)
5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line raelJournal of Virology, 63
F. Maly, M. Nakamura, J. Gauchat, A. Urwyler, C. Walker, C. Dahinden, A. Cross, O. Jones, A. Weck (1989)
Superoxide-dependent nitroblue tetrazolium reduction and expression of cytochrome b-245 components by human tonsillar B lymphocytes and B cell lines.Journal of immunology, 142 4
Catherine Darr, A. Mauser, S. Kenney (2001)
Epstein-Barr Virus Immediate-Early Protein BRLF1 Induces the Lytic Form of Viral Replication through a Mechanism Involving Phosphatidylinositol-3 Kinase ActivationJournal of Virology, 75
R. Tibbetts, K. Brumbaugh, Josie Williams, J. Sarkaria, W. Cliby, S. Shieh, Y. Taya, C. Prives, R. Abraham (1999)
A role for ATR in the DNA damage-induced phosphorylation of p53.Genes & development, 13 2
Xiao-Peng Zhang, Feng Liu, Wei Wang (2011)
Two-phase dynamics of p53 in the DNA damage responseProceedings of the National Academy of Sciences, 108
Zhi Guo, S. Kozlov, M. Lavin, M. Person, T. Paull (2010)
ATM Activation by Oxidative StressScience, 330
Fengchun Ye, A. Lattif, Jianping Xie, A. Weinberg, Shoujiang Gao (2012)
Nutlin-3 induces apoptosis, disrupts viral latency and inhibits expression of angiopoietin-2 in Kaposi sarcoma tumor cellsCell Cycle, 11
D. Sarbassov, D. Guertin, Siraj Ali, D. Sabatini (2005)
Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR ComplexScience, 307
E. Westphal, W. Blackstock, W. Feng, Bruce Israel, S. Kenney (2000)
Activation of lytic Epstein-Barr virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo: a potential method for treating EBV-positive malignancies.Cancer research, 60 20
H. Hausen, H. Schulte‐Holthausen, G. Klein, W. Henle, G. Henle, P. Clifford, L. Santesson (1970)
Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the NasopharynxNature, 228
Cheryl Miller, R. Longnecker, E. Kieff (1993)
Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytesJournal of Virology, 67
W. Feng, S. Kenney (2006)
Valproic acid enhances the efficacy of chemotherapy in EBV-positive tumors by increasing lytic viral gene expression.Cancer research, 66 17
J. Countryman, H. Jenson, R. Seibl, H. Wolf, G. Miller (1987)
Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latencyJournal of Virology, 61
C. Nonkwelo, J. Skinner, A. Bell, A. Rickinson, J. Sample (1996)
Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 proteinJournal of Virology, 70
C Rooney, D. Rowe, T. Ragot, P. Farrell (1989)
The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycleJournal of Virology, 63
A. Nanbo, Kaori Inoue, Kumi Adachi-Takasawa, K. Takada (2002)
Epstein–Barr virus RNA confers resistance to interferon‐α‐induced apoptosis in Burkitt's lymphomaThe EMBO Journal, 21
C. Miller, Jennifer Lee, E. Kieff, R. Longnecker (1994)
An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking.Proceedings of the National Academy of Sciences of the United States of America, 91
John Greenspan, Deborah Greenspan, Evelyne Lennette (1985)
Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion.The New England journal of medicine, 313 25
C. Gregory, M. Rowe, A. Rickinson (1990)
Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.The Journal of general virology, 71 ( Pt 7)
L. Vassilev, B. Vu, B. Graves, D. Carvajal, F. Podlaski, Z. Filipovic, Norman Kong, U. Kammlott, C. Lukacs, C. Klein, N. Fotouhi, E. Liu (2004)
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2Science, 303
Amy Adamson, S. Kenney (1998)
Rescue of the Epstein-Barr virus BZLF1 mutant, Z(S186A), early gene activation defect by the BRLF1 gene product.Virology, 251 1
P. Nikitin, Chris Yan, E. Forte, A. Bocedi, Jason Tourigny, Amee Patel, S. Dave, Katherine Hu, Jing Guo, David Tainter, O. Rusyn, M. Luftig (2010)
An ATM/Chk2-mediated DNA damage responsive signaling pathway suppresses Epstein-Barr virus transformation of primary human B cellsInfectious Agents and Cancer, 5
Kai Chen, Adam Albano, A. Ho, J. Keaney (2003)
Activation of p53 by Oxidative Stress Involves Platelet-derived Growth Factor-β Receptor-mediated Ataxia Telangiectasia Mutated (ATM) Kinase Activation*Journal of Biological Chemistry, 278
E. Kieff (1996)
Epstein-Barr virus and its replication
R. Husaini, Munirah Ahmad, Alan Khoo (2011)
Epstein-Barr virus Latent Membrane Protein LMP1 reduces p53 protein levels independent of the PI3K-Akt pathwayBMC Research Notes, 4
S. Shieh, M. Ikeda, Y. Taya, C. Prives (1997)
DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2Cell, 91
W. Feng, Bruce Israel, N. Raab-Traub, P. Busson, S. Kenney (2002)
Chemotherapy induces lytic EBV replication and confers ganciclovir susceptibility to EBV-positive epithelial cell tumors.Cancer research, 62 6
Bettina Gruhne, R. Sompallae, M. Masucci (2009)
Three Epstein–Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpointsOncogene, 28
A. Kudoh, M. Fujita, Lumin Zhang, Noriko Shirata, T. Daikoku, Y. Sugaya, Hiroki Isomura, Y. Nishiyama, T. Tsurumi (2005)
Epstein-Barr Virus Lytic Replication Elicits ATM Checkpoint Signal Transduction While Providing an S-phase-like Cellular Environment*Journal of Biological Chemistry, 280
Xudong Li, Jiaying Feng, R. Sun (2010)
Oxidative Stress Induces Reactivation of Kaposi's Sarcoma-Associated Herpesvirus and Death of Primary Effusion Lymphoma CellsJournal of Virology, 85
S. Matsuoka, B. Ballif, A. Smogorzewska, A. Smogorzewska, E. McDonald, Kristen Hurov, Ji Luo, C. Bakalarski, Zhenming Zhao, N. Solimini, Y. Lerenthal, Y. Shiloh, S. Gygi, S. Elledge (2007)
ATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA DamageScience, 316
Lees-Miller (1992)
Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53Mol. Cell. Biol., 12
Taewan Kim, A. Veronese, F. Pichiorri, T. Lee, Young-Jun Jeon, S. Volinia, P. Pineau, A. Marchio, J. Palatini, S. Suh, H. Alder, Chang-gong Liu, A. Dejean, C. Croce (2011)
p53 regulates epithelial–mesenchymal transition through microRNAs targeting ZEB1 and ZEB2The Journal of Experimental Medicine, 208
Shmuel Ben‐Ssson, G. Klein (1981)
Activation of the epstein‐barr virus genome by 5‐aza‐cytidine in latently infected human lymphoid linesInternational Journal of Cancer, 28
Pei-Ching Chang, L. Fitzgerald, A. Geelen, Y. Izumiya, Thomas Ellison, Don-Hong Wang, D. Ann, P. Luciw, H. Kung (2009)
Kruppel-associated box domain-associated protein-1 as a latency regulator for Kaposi's sarcoma-associated herpesvirus and its modulation by the viral protein kinase.Cancer research, 69 14
Shidong Ma, Xianming Yu, J. Mertz, J. Gumperz, Erik Reinheim, Ying Zhou, Wei-hua Tang, W. Burlingham, M. Gulley, S. Kenney (2012)
An Epstein-Barr Virus (EBV) Mutant with Enhanced BZLF1 Expression Causes Lymphomas with Abortive Lytic EBV Infection in a Humanized Mouse ModelJournal of Virology, 86
S. Bhatti, S. Kozlov, A. Farooqi, A. Naqi, M. Lavin, K. Khanna (2011)
ATM protein kinase: the linchpin of cellular defenses to stressCellular and Molecular Life Sciences, 68
Q. Meng, Stacy Hagemeier, Chad Kuny, R. Kalejta, S. Kenney (2010)
Simian Virus 40 T/t Antigens and Lamin A/C Small Interfering RNA Rescue the Phenotype of an Epstein-Barr Virus Protein Kinase (BGLF4) MutantJournal of Virology, 84
Zhi Guo, R. Deshpande, T. Paull (2010)
ATM activation in the presence of oxidative stressCell Cycle, 9
J. Webster-Cyriaque, Jaap Middeldorp, N. Raab-Traub (2000)
Hairy Leukoplakia: an Unusual Combination of Transforming and Permissive Epstein-Barr Virus InfectionsJournal of Virology, 74
Rickenson (2007)
Epstein-Barr virus
H. Delecluse, Tanja Hilsendegen, D. Pich, Reinhard Zeidler, W. Hammerschmidt (1998)
Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells.Proceedings of the National Academy of Sciences of the United States of America, 95 14
S. Kenney, J. Kamine, E. Holley-Guthrie, Jung-Chung Lin, E. Mar, Joseph Pagano (1989)
The Epstein-Barr virus (EBV) BZLF1 immediate-early gene product differentially affects latent versus productive EBV promotersJournal of Virology, 63
K. Wiman, K. Magnússon, T. Ramqvist, G. Klein (1991)
Mutant p53 detected in a majority of Burkitt lymphoma cell lines by monoclonal antibody PAb240.Oncogene, 6 9
Kenzo, Takada, Norio Shimizu, '. Sakuma (1986)
trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragmentJournal of Virology, 57
T. Kanda, Misako Yajima, N. Ahsan, Mika Tanaka, K. Takada (2004)
Production of High-Titer Epstein-Barr Virus Recombinants Derived from Akata Cells by Using a Bacterial Artificial Chromosome SystemJournal of Virology, 78
Amy Adamson, S. Kenney (2001)
Epstein-Barr Virus Immediate-Early Protein BZLF1 Is SUMO-1 Modified and Disrupts Promyelocytic Leukemia BodiesJournal of Virology, 75
E. Forte, M. Luftig (2009)
MDM2-dependent inhibition of P53 is required for Epstein-Barr virus B cell growth transformation and infected cell survivalInfectious Agents and Cancer, 4
Sarah Dickerson, Y. Xing, A. Robinson, W. Seaman, H. Gruffat, S. Kenney (2009)
Methylation-Dependent Binding of the Epstein-Barr Virus BZLF1 Protein to Viral PromotersPLoS Pathogens, 5
A. Chevallier-Greco, E. Manet, P. Chavrier, C. Mosnier, J. Daillie, A. Sergeant (1986)
Both Epstein‐Barr virus (EBV)‐encoded trans‐acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter.The EMBO Journal, 5
Frederick Derheimer, M. Kastan (2010)
Multiple roles of ATM in monitoring and maintaining DNA integrityFEBS Letters, 584
B. Adler, Eveline Schaadt, B. Kempkes, U. Zimber-Strobl, B. Baier, G. Bornkamm (2001)
Control of Epstein–Barr virus reactivation by activated CD40 and viral latent membrane protein 1Proceedings of the National Academy of Sciences of the United States of America, 99
E. Forte, M. Luftig (2009)
MDM2-Dependent Inhibition of p53 Is Required for Epstein-Barr Virus B-Cell Growth Transformation and Infected-Cell SurvivalJournal of Virology, 83
J Hardwick, P. Lieberman, S. Hayward (1988)
A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigenJournal of Virology, 62
S. Lees-Miller, K. Sakaguchi, S. Ullrich, E. Appella, C. Anderson (1992)
Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53Molecular and Cellular Biology, 12
Shouting Zhang, M. Ekman, Noopur Thakur, Shizhong Bu, P. Davoodpour, S. Grimsby, Seicchi Tagami, C. Heldin, M. Landström (2006)
TGFβ1-Induced Activation of ATM and p53 Mediates Apoptosis in a Smad7-Dependent MannerCell Cycle, 5
Qiliang Cai, Yi Guo, Bingyi Xiao, Shuvomoy Banerjee, A. Saha, Jie Lu, Tina Glisovic, E. Robertson (2011)
Epstein-Barr Virus Nuclear Antigen 3C Stabilizes Gemin3 to Block p53-mediated ApoptosisPLoS Pathogens, 7
J. Luka, B. Kallin, G. Klein (1979)
Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate.Virology, 94 1
V. Tarakanova, V. Leung-Pineda, Seungmin Hwang, Chiao-Wen Yang, K. Matatall, Mickael Basson, R. Sun, H. Piwnica-Worms, B. Sleckman, H. Virgin (2007)
Gamma-herpesvirus kinase actively initiates a DNA damage response by inducing phosphorylation of H2AX to foster viral replication.Cell host & microbe, 1 4
Gregory Hong, H. Delecluse, H. Gruffat, T. Morrison, W. Feng, A. Sergeant, S. Kenney (2004)
The BRRF1 Early Gene of Epstein-Barr Virus Encodes a Transcription Factor That Enhances Induction of Lytic Infection by BRLF1Journal of Virology, 78
Jill Countryman, George MILLERt (1985)
Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA.Proceedings of the National Academy of Sciences of the United States of America, 82 12
P. Bhende, W. Seaman, H. Delecluse, S. Kenney (2005)
BZLF1 Activation of the Methylated Form of the BRLF1 Immediate-Early Promoter Is Regulated by BZLF1 Residue 186Journal of Virology, 79
H. Gruffat, E. Manet, Agnès Rigolet, A. Sergeant (1990)
The enhancer factor R of Epstein-Barr virus (EBV) is a sequence-specific DNA binding protein.Nucleic acids research, 18 23
H. Fahmi, C. Cochet, Z. Hmama, P. Opolon, I. Joab (2000)
Transforming Growth Factor Beta 1 Stimulates Expression of the Epstein-Barr Virus BZLF1 Immediate-Early Gene Product ZEBRA by an Indirect Mechanism Which Requires the MAPK Kinase PathwayJournal of Virology, 74
Stuart Prince, Sinéad Keating, C. Fielding, P. Brennan, Eike Floettmann, M. Rowe (2003)
Latent Membrane Protein 1 Inhibits Epstein-Barr Virus Lytic Cycle Induction and Progress via Different MechanismsJournal of Virology, 77
K. Takada, Y. Ono (1989)
Synchronous and sequential activation of latently infected Epstein-Barr virus genomesJournal of Virology, 63
Lauri Laichalk, D. Thorley-Lawson (2005)
Terminal Differentiation into Plasma Cells Initiates the Replicative Cycle of Epstein-Barr Virus In VivoJournal of Virology, 79
Journal of Virology – Unpaywall
Published: Sep 27, 2012
Access the full text.
Sign up today, get DeepDyve free for 14 days.